ISATUXIMAB-IRFC

ISATUXIMAB-IRFC was reported 54 times

ISATUXIMAB-IRFC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELOCYTE PERCENTAGE DECREASED 1 0.3333
1 PULMONARY VENOUS HYPERTENSION 1 0.0769
2 MYELOCYTE COUNT DECREASED 1 0.0714
3 CANCER SCREENING ABNORMAL 1 0.0526
4 PSEUDOMONAS PERITONITIS 1 0.0278
5 PLASMA CELLS INCREASED 1 0.0137
6 PATERNAL DRUGS AFFECTING FOETUS 1 0.0027
7 MARROW HYPERPLASIA 1 0.0015
8 OESOPHAGITIS ULCERATIVE 1 0.0015
9 PREGNANCY OF PARTNER 1 0.0014
10 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
11 NON-CARDIAC CHEST PAIN 2 0.0006
12 PLASMACYTOMA 1 0.0005
13 EOSINOPHIL COUNT DECREASED 1 0.0004
14 STEM CELL TRANSPLANT 1 0.0004
15 URINARY TRACT INFECTION BACTERIAL 1 0.0004
16 BILIARY COLIC 1 0.0003
17 STRIDOR 1 0.0003
18 ARTHRITIS BACTERIAL 1 0.0002
19 ILEUS PARALYTIC 1 0.0002
20 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
21 PATHOLOGICAL FRACTURE 1 0.0002
22 COVID-19 PNEUMONIA 2 0.0002
23 HYPOGAMMAGLOBULINAEMIA 1 0.0002
24 NEUTROPHIL COUNT DECREASED 5 0.0001
25 INFUSION SITE ERYTHEMA 1 0.0001
26 ANAL INCONTINENCE 1 0.0001
27 UROSEPSIS 1 0.0001
28 NEUTROPHIL COUNT INCREASED 1 0.0001
29 HYPERTENSIVE CRISIS 1 0.0001
30 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
31 BACTERAEMIA 1 0.0001
32 CYTOPENIA 1 0.0001
33 RESPIRATORY DEPRESSION 1 0.0001
34 ILEUS 1 0.0001
35 SARS-COV-2 TEST POSITIVE 1 0.0001
36 TACHYPNOEA 1 0.0001
37 NEUTROPENIA 9 0.0001
38 MUSCULOSKELETAL CHEST PAIN 1 0.0001
39 SENSORY DISTURBANCE 1 0.0001
40 URINARY RETENTION 2 0.0001
41 PELVIC PAIN 1 0.0001
42 PLASMA CELL MYELOMA 2 0.0001
43 CYTOKINE RELEASE SYNDROME 1 0.0000
44 FULL BLOOD COUNT DECREASED 1 0.0000
45 RETCHING 1 0.0000
46 INFUSION RELATED REACTION 3 0.0000
47 TOOTH DISORDER 1 0.0000
48 HYPOKALAEMIA 2 0.0000
49 OSTEONECROSIS OF JAW 1 0.0000
50 CELLULITIS 2 0.0000
51 DIPLOPIA 1 0.0000
52 SKIN LESION 1 0.0000
53 RESPIRATORY DISTRESS 1 0.0000
54 ANAPHYLACTIC REACTION 2 0.0000
55 MENTAL STATUS CHANGES 1 0.0000
56 URINARY TRACT INFECTION 6 0.0000
57 HAEMATURIA 1 0.0000
58 DELIRIUM 1 0.0000
59 NEOPLASM PROGRESSION 1 0.0000
60 HYPOXIA 1 0.0000
61 PLATELET COUNT DECREASED 3 0.0000
62 MYELOSUPPRESSION 1 0.0000
63 DYSPNOEA EXERTIONAL 1 0.0000
64 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
65 SEPTIC SHOCK 1 0.0000
66 RENAL DISORDER 1 0.0000
67 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
68 LEUKOPENIA 1 0.0000
69 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
70 OEDEMA 1 0.0000
71 THROMBOCYTOPENIA 2 0.0000
72 HERPES ZOSTER 1 0.0000
73 CATARACT 1 0.0000
74 EXPOSURE DURING PREGNANCY 1 0.0000
75 AMNESIA 1 0.0000
76 FEBRILE NEUTROPENIA 1 0.0000
77 THERAPY INTERRUPTED 1 0.0000
78 SKIN BURNING SENSATION 1 0.0000
79 ABDOMINAL PAIN 3 0.0000
80 CARDIAC FAILURE CONGESTIVE 1 0.0000
81 COVID-19 2 0.0000
82 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
83 OROPHARYNGEAL PAIN 1 0.0000
84 CHEST PAIN 2 0.0000
85 DYSPHAGIA 1 0.0000
86 NEUROPATHY PERIPHERAL 1 0.0000
87 ANAEMIA 2 0.0000
88 GAIT DISTURBANCE 2 0.0000
89 ATRIAL FIBRILLATION 1 0.0000
90 HYPOTENSION 2 0.0000
91 FLUSHING 1 0.0000
92 HAEMOGLOBIN DECREASED 1 0.0000
93 PNEUMONIA 3 0.0000
94 INFLUENZA 1 0.0000
95 SEPSIS 1 0.0000
96 SEIZURE 1 0.0000
97 CHILLS 1 0.0000
98 OEDEMA PERIPHERAL 1 0.0000
99 VISUAL IMPAIRMENT 1 0.0000
100 LOSS OF CONSCIOUSNESS 1 0.0000
101 RENAL FAILURE 1 0.0000
102 DEHYDRATION 1 0.0000
103 WEIGHT DECREASED 2 0.0000
104 MALAISE 3 0.0000
105 CONDITION AGGRAVATED 2 0.0000
106 PERIPHERAL SWELLING 1 0.0000
107 PARAESTHESIA 1 0.0000
108 TOXICITY TO VARIOUS AGENTS 1 0.0000
109 PYREXIA 2 0.0000
110 NO ADVERSE EVENT 1 0.0000
111 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
112 HEADACHE 3 0.0000
113 HYPERTENSION 1 0.0000
114 CONSTIPATION 1 0.0000
115 WEIGHT INCREASED 1 0.0000
116 BACK PAIN 1 0.0000
117 DIZZINESS 2 0.0000
118 INSOMNIA 1 0.0000
119 DYSPNOEA 2 0.0000
120 OFF LABEL USE 3 0.0000
121 PAIN IN EXTREMITY 1 0.0000
122 FALL 1 0.0000
123 FATIGUE 2 0.0000
124 NAUSEA 2 0.0000
125 DEATH 2 0.0000
126 RASH 1 0.0000
127 DIARRHOEA 1 0.0000
128 DRUG INEFFECTIVE 1 0.0000